185 related articles for article (PubMed ID: 9533525)
1. Minimal recruitment and activation of dendritic cells within renal cell carcinoma.
Troy AJ; Summers KL; Davidson PJ; Atkinson CH; Hart DN
Clin Cancer Res; 1998 Mar; 4(3):585-93. PubMed ID: 9533525
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical analysis of HLA class II antigens and tumor infiltrating mononuclear cells in renal cell carcinoma: correlation with clinical and histopathological data.
Brasanac D; Marković-Lipkovski J; Hadzi-Djokić J; Müller GA; Müller CA
Neoplasma; 1999; 46(3):173-8. PubMed ID: 10613593
[TBL] [Abstract][Full Text] [Related]
3. Immunosuppressive effect of renal cell carcinoma on phenotype and function of dendritic cells.
Teng L; Chen Y; Ding D; Dai H; Liu G; Li C
Int Urol Nephrol; 2014 May; 46(5):915-20. PubMed ID: 24202958
[TBL] [Abstract][Full Text] [Related]
4. Human renal cell carcinoma induces a dendritic cell subset that uses T-cell crosstalk for tumor-permissive milieu alterations.
Figel AM; Brech D; Prinz PU; Lettenmeyer UK; Eckl J; Turqueti-Neves A; Mysliwietz J; Anz D; Rieth N; Muenchmeier N; Buchner A; Porubsky S; Siegert SI; Segerer S; Nelson PJ; Noessner E
Am J Pathol; 2011 Jul; 179(1):436-51. PubMed ID: 21703422
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of activation markers in renal cell carcinoma infiltrating lymphocytes.
Shabtai M; Ye H; Frischer Z; Martin J; Waltzer WC; Malinowski K
J Urol; 2002 Nov; 168(5):2216-9. PubMed ID: 12394762
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic characterization of infiltrating leukocytes in benign prostatic hyperplasia.
Theyer G; Kramer G; Assmann I; Sherwood E; Preinfalk W; Marberger M; Zechner O; Steiner GE
Lab Invest; 1992 Jan; 66(1):96-107. PubMed ID: 1370561
[TBL] [Abstract][Full Text] [Related]
7. Dysfunctional DC subsets in RCC patients: ex vivo correction to yield an effective anti-cancer vaccine.
Gigante M; Blasi A; Loverre A; Mancini V; Battaglia M; Selvaggi FP; Maiorano E; Napoli A; Castellano G; Storkus WJ; Gesualdo L; Ranieri E
Mol Immunol; 2009 Feb; 46(5):893-901. PubMed ID: 19041139
[TBL] [Abstract][Full Text] [Related]
8. In vivo description of dendritic cells in human renal cell carcinoma.
Schwaab T; Schned AR; Heaney JA; Cole BF; Atzpodien J; Wittke F; Ernstoff MS
J Urol; 1999 Aug; 162(2):567-73. PubMed ID: 10411089
[TBL] [Abstract][Full Text] [Related]
9. Characterization of antigen-presenting cells in human apical periodontitis lesions by flow cytometry and immunocytochemistry.
Lukić A; Vasilijić S; Majstorović I; Vucević D; Mojsilović S; Gazivoda D; Danilović V; Petrović R; Colić M
Int Endod J; 2006 Aug; 39(8):626-36. PubMed ID: 16872457
[TBL] [Abstract][Full Text] [Related]
10. Immunomodulatory dendritic cells generated from nonfractionated bulk peripheral blood mononuclear cell cultures induce growth of cytotoxic T cells against renal cell carcinoma.
Hinkel A; Tso CL; Gitlitz BJ; Neagos N; Schmid I; Paik SH; deKernion J; Figlin R; Belldegrun A
J Immunother; 2000 Jan; 23(1):83-93. PubMed ID: 10687141
[TBL] [Abstract][Full Text] [Related]
11. Generation of CMRF-44+ monocyte-derived dendritic cells: insights into phenotype and function.
Vuckovic S; Fearnley DB; Mannering SI; Dekker J; Whyte LF; Hart DN
Exp Hematol; 1998 Dec; 26(13):1255-64. PubMed ID: 9845382
[TBL] [Abstract][Full Text] [Related]
12. Presentation of renal tumor antigens by human dendritic cells activates tumor-infiltrating lymphocytes against autologous tumor: implications for live kidney cancer vaccines.
Mulders P; Tso CL; Gitlitz B; Kaboo R; Hinkel A; Frand S; Kiertscher S; Roth MD; deKernion J; Figlin R; Belldegrun A
Clin Cancer Res; 1999 Feb; 5(2):445-54. PubMed ID: 10037196
[TBL] [Abstract][Full Text] [Related]
13. Human renal-cell carcinoma tissue contains dendritic cells.
Thurnher M; Radmayr C; Ramoner R; Ebner S; Böck G; Klocker H; Romani N; Bartsch G
Int J Cancer; 1996 Sep; 68(1):1-7. PubMed ID: 8895531
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the response of dendritic cells and regulatory T cells to tumor antigens in patients with renal cell carcinoma.
Hou MM; Chang JW; Pang ST; Chiang YJ; Shen YC; Liao SK; Hsieh JJ; Yeh KY; Chang NJ; Chuang CK
Chang Gung Med J; 2010; 33(1):25-35. PubMed ID: 20184792
[TBL] [Abstract][Full Text] [Related]
15. Isolation of human blood dendritic cells using the CMRF-44 monoclonal antibody: implications for studies on antigen-presenting cell function and immunotherapy.
Fearnley DB; McLellan AD; Mannering SI; Hock BD; Hart DN
Blood; 1997 May; 89(10):3708-16. PubMed ID: 9160676
[TBL] [Abstract][Full Text] [Related]
16. [Immunohistochemical analysis of CD83, CD8 and CD4 positive cells in renal cell carcinoma].
Aso T; Ogawa Y; Naoe M; Fukagai T; Yoshida H; Kushima M
Nihon Hinyokika Gakkai Zasshi; 2004 May; 95(4):645-50. PubMed ID: 15197997
[TBL] [Abstract][Full Text] [Related]
17. Dermal dendritic cells associated with T lymphocytes in normal human skin display an activated phenotype.
McLellan AD; Heiser A; Sorg RV; Fearnley DB; Hart DN
J Invest Dermatol; 1998 Nov; 111(5):841-9. PubMed ID: 9804348
[TBL] [Abstract][Full Text] [Related]
18. Mature dendritic cells make clusters with T cells in the invasive margin of colorectal carcinoma.
Suzuki A; Masuda A; Nagata H; Kameoka S; Kikawada Y; Yamakawa M; Kasajima T
J Pathol; 2002 Jan; 196(1):37-43. PubMed ID: 11748640
[TBL] [Abstract][Full Text] [Related]
19. Regulatory T cells, dendritic cells and neutrophils in patients with renal cell carcinoma.
Minárik I; Lašťovička J; Budinský V; Kayserová J; Spíšek R; Jarolím L; Fialová A; Babjuk M; Bartůňková J
Immunol Lett; 2013 May; 152(2):144-50. PubMed ID: 23721909
[TBL] [Abstract][Full Text] [Related]
20. Phenotype, cytokine production and cytolytic capacity of fresh (uncultured) tumour-infiltrating T lymphocytes in human renal cell carcinoma.
Van den Hove LE; Van Gool SW; Van Poppel H; Baert L; Coorevits L; Van Damme B; Ceuppens JL
Clin Exp Immunol; 1997 Sep; 109(3):501-9. PubMed ID: 9328129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
